Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections

<i>Clostridioides difficile</i> infections (CDIs) have decreased in the past years, but since 2021, some hospitals have reported an increase in CDI rates. CDI remains a global concern and has been identified as an urgent threat to healthcare. Although multiple treatment options are avail...

Full description

Bibliographic Details
Main Authors: Lynne V. McFarland, Ellie J. C. Goldstein, Ravina Kullar
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/11/6/1534
_version_ 1797593410604892160
author Lynne V. McFarland
Ellie J. C. Goldstein
Ravina Kullar
author_facet Lynne V. McFarland
Ellie J. C. Goldstein
Ravina Kullar
author_sort Lynne V. McFarland
collection DOAJ
description <i>Clostridioides difficile</i> infections (CDIs) have decreased in the past years, but since 2021, some hospitals have reported an increase in CDI rates. CDI remains a global concern and has been identified as an urgent threat to healthcare. Although multiple treatment options are available, prevention strategies are more limited. As CDI is an opportunistic infection that arises after the normally protective microbiome has been disrupted, preventive measures aimed at restoring the microbiome have been tested. Our aim is to update the present knowledge on these various preventive strategies published in the past five years (2018–2023) to guide clinicians and healthcare systems on how to best prevent CDI. A literature search was conducted using databases (PubMed, Google Scholar, and clinicaltrials.gov) for phase 2–3 clinical trials for the primary or secondary prevention of CDI and microbiome and probiotics. As the main factor for <i>Clostridium difficile</i> infections is the disruption of the normally protective intestinal microbiome, strategies aimed at restoring the microbiome seem most rational. Some strains of probiotics, the use of fecal microbial therapy, and live biotherapeutic products offer promise to fill this niche; although, more large randomized controlled trials are needed that document the shifts in the microbiome population.
first_indexed 2024-03-11T02:08:43Z
format Article
id doaj.art-d93706d8eed14b5b978660575c36f42e
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-11T02:08:43Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-d93706d8eed14b5b978660575c36f42e2023-11-18T11:43:13ZengMDPI AGMicroorganisms2076-26072023-06-01116153410.3390/microorganisms11061534Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> InfectionsLynne V. McFarland0Ellie J. C. Goldstein1Ravina Kullar2McFarland Consulting, Seattle, WA 98115, USAR.M. Alden Research Laboratory, Santa Monica, CA 90404, USAExpert Stewardship Inc., Newport Beach, CA 92663, USA<i>Clostridioides difficile</i> infections (CDIs) have decreased in the past years, but since 2021, some hospitals have reported an increase in CDI rates. CDI remains a global concern and has been identified as an urgent threat to healthcare. Although multiple treatment options are available, prevention strategies are more limited. As CDI is an opportunistic infection that arises after the normally protective microbiome has been disrupted, preventive measures aimed at restoring the microbiome have been tested. Our aim is to update the present knowledge on these various preventive strategies published in the past five years (2018–2023) to guide clinicians and healthcare systems on how to best prevent CDI. A literature search was conducted using databases (PubMed, Google Scholar, and clinicaltrials.gov) for phase 2–3 clinical trials for the primary or secondary prevention of CDI and microbiome and probiotics. As the main factor for <i>Clostridium difficile</i> infections is the disruption of the normally protective intestinal microbiome, strategies aimed at restoring the microbiome seem most rational. Some strains of probiotics, the use of fecal microbial therapy, and live biotherapeutic products offer promise to fill this niche; although, more large randomized controlled trials are needed that document the shifts in the microbiome population.https://www.mdpi.com/2076-2607/11/6/1534<i>C. difficile</i> infectionspreventionlive biological productprobiotics
spellingShingle Lynne V. McFarland
Ellie J. C. Goldstein
Ravina Kullar
Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
Microorganisms
<i>C. difficile</i> infections
prevention
live biological product
probiotics
title Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
title_full Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
title_fullStr Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
title_full_unstemmed Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
title_short Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
title_sort microbiome related and infection control approaches to primary and secondary prevention of i clostridioides difficile i infections
topic <i>C. difficile</i> infections
prevention
live biological product
probiotics
url https://www.mdpi.com/2076-2607/11/6/1534
work_keys_str_mv AT lynnevmcfarland microbiomerelatedandinfectioncontrolapproachestoprimaryandsecondarypreventionoficlostridioidesdifficileiinfections
AT elliejcgoldstein microbiomerelatedandinfectioncontrolapproachestoprimaryandsecondarypreventionoficlostridioidesdifficileiinfections
AT ravinakullar microbiomerelatedandinfectioncontrolapproachestoprimaryandsecondarypreventionoficlostridioidesdifficileiinfections